The drug maker said it is ‘firmly committed to investing and growing in the US’ amid potential import tariffs on the ...

The chief executive of AstraZeneca said on Tuesday that the drugmaker will maintain its 2025 sales guidance even if the U.S.

AstraZeneca CEO Pascal Soriot discusses earnings, the potential trade tariff impact on the business and the outlook for the firm's key markets.

AstraZeneca on Tuesday said it had received an opinion from authorities in Shenzhen city of suspected unpaid import taxes of ...

The Anglo-Swedish pharmaceutical group on Tuesday reported revenue of $13.6bn in the first three months of the year, up 10 ...

But so far, so good for the TROP2-directed treatment, which is off to a "smooth market launch,” according to Daiichi CEO ...

On a per-share basis, the Cambridge, Britain-based company said it had profit of 93 cents. Earnings, adjusted for non-recurring costs, came to $1.24 per share. The results topped Wall Street ...

"Our collaboration with AstraZeneca represents a significant step toward scaling next-generation oncology diagnostics ...

AstraZeneca Plc’s Chief Executive Officer Pascal Soriot warned that trade tariffs are not the best way to manage ...

LONDON: British pharmaceutical giant AstraZeneca on Tuesday vowed to keep investing and growing its business in ...

AstraZeneca stuck to its 2025 financial targets and said it was committed to investing and growing in the U.S. as the industry faces President Trump's tariff threats. AstraZeneca last year pledged ...